-
Mashup Score: 12ASM Microbe Conference: 'Great Migration of Microbiologists' - 14 day(s) ago
American Society for Microbiology (ASM) CEO Stefano Bertuzzi, PhD, MPH, talks about its comprehensive scientific program, the networking opportunities at the meeting, and the unique format it plans to roll out for the 2026 conference.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 4A Pioneer in Coronavirus Research - 15 day(s) ago
In a wide-ranging interview, Susan Weiss, PhD, talks about winning the ASM Lifetime Achievement award, her work on coronaviruses, and her concerns around federal government funding and how it may shake up and limit basic science research.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
Susan Weiss, PhD, talks about winning the ASM Lifetime Achievement award, her work on coronaviruses, and her concerns around federal government funding and how it may shake up and limit basic science research. #ASMicrobe2025 https://t.co/bRSEdoHRNe
-
-
Mashup Score: 03 Deaths and 17 Illnesses Tied to Listeria Outbreak From Recalled Chicken Alfredo Meals - 16 day(s) ago
FDA and CDC warn consumers as recalled heat-and-eat meals sold at Kroger and Walmart are tied to multiple hospitalizations, one pregnancy loss, and ongoing risks.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
🚨 3 Deaths, 17 Sickened in Listeria Outbreak 🚨 A multistate outbreak tied to prepackaged chicken alfredo meals sold at Kroger and Walmart has led to 3 deaths, in IL, MI, and TX, along with 16 hospitalizations and 1 pregnancy loss across 13 states. https://t.co/Xu7lP2r149
-
-
Mashup Score: 0Bloodstream Infections in Ethiopia Reveal High Rates of Multidrug Resistance and Fungal Involvement - 16 day(s) ago
At ASM Microbe 2025, a cross-sectional study highlights Burkholderia cepacia dominance, widespread antibiotic resistance, and key risk factors, including invasive device use and patient demographics.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
At #ASMicrobe2025, a study from Ethiopia reveals alarming rates of multidrug-resistant bloodstream infections, Burkholderia cepacia and Candida krusei top the list, highlighting urgent needs for stronger infection control & AMR stewardship. Read more: https://t.co/IdCzquRN0t
-
-
Mashup Score: 0
At the ASM Microbe conference, Mike Bromley, PhD, offers some insights on the importance of a One Health approach addressing the growing antifungal resistance to azoles and Aspergillus fumigatus because of the connection between crop spraying and the rise of resistance.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
At the #ASMMicrobe2025 conference, Dr. Mike Bromley, offers some insights on the importance of a One Health approach addressing the growing antifungal resistance to azoles and Aspergillus fumigatus. https://t.co/HT2jeIGyDB
-
-
Mashup Score: 1
At ASM Microbe 2025, researchers underscore the role of NAAT in outpatient CDI diagnosis and raise concerns over PPI-related risk in older, healthcare-associated cases.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
Outpatient CDI study from #ASMicrobe2025 reveals diagnostic gaps where NAAT confirms GDH+/toxin– cases. PPI use remains a key risk factor, especially in older patients with prior healthcare exposure. @ASMicrobiology Read more: https://t.co/hSU9aVAXKn
-
-
Mashup Score: 1Evolving Challenges in C difficile Testing: Diagnostic Stewardship or Laboratory Retrogress? - 17 day(s) ago
Study presented at ASM Microbe 2025 questions the clinical value of adding enzyme immunoassays to PCR-based CDI diagnostics amid sensitivity concerns.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
New data from #ASMMicrobe2025 challenges the role of enzyme immunoassays in C difficile testing. Are we advancing diagnostic stewardship, or taking a step back? PCR remains more sensitive, but the debate over specificity continues. Read more: https://t.co/5klTuAelJL
-
-
Mashup Score: 5Latest Conference - 17 day(s) ago
Contagion® is a fully integrated news resource for practitioners and specialists to assist with the identification, diagnosis, treatment, and prevention of infectious diseases.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
Had an incredible time at the #WorldAMRCongress! Don’t forget to check out our expert interviews on our site. We’re excited to share more conversations from the event soon. Stay tuned! https://t.co/CLIykL2lrw https://t.co/mVh0TgVD3Z
-
-
Mashup Score: 1
Presented at ASM Microbe 2025, a bioinformatics study highlights nine human miRNAs capable of binding and potentially inhibiting both hepatitis C and bovine viral diarrhea viruses.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
New research presented at #ASMMicrobe2025 reveals 9 human miRNAs that could simultaneously target both Hepatitis C and BVDV. A promising step toward dual-acting antiviral therapies. Read more: https://t.co/GTlkOdVht8
-
-
Mashup Score: 31FDA Approves Gilead’s Twice-Yearly Injectable Yeztugo (Lenacapavir) for HIV Prevention - 17 day(s) ago
Gilead’s lenacpavir, la ong-acting HIV capsid inhibitor shows 96–100% efficacy in phase 3 trials and aims to expand access worldwide through regulatory filings and support programs.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
❗BREAKING: @US_FDA approved @GileadSciences Yeztugo (lenacapavir) for HIV-1 PrEP, the first twice-yearly injectable option. The approval is based on the PURPOSE trials showing ≥99.9% prevention efficacy. Our interview with Dr. Jared Baeten: from Gilead https://t.co/sjm3aEB4XO
-
.@ASMicrobiology CEO Stefano Bertuzzi, PhD, MPH, talks about its comprehensive scientific program, the networking opportunities at the meeting, and the unique format it plans to roll out for the 2026 conference. #ASMmicrobe2025 https://t.co/JHSsOV5wZy